Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs RingCentral Inc. Class A Common Stock (RNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs RingCentral Inc. Class A Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while RingCentral Inc. Class A Common Stock trades at $79.59 (market cap $6.54B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and RingCentral Inc. Class A Common Stock pays a 0.35% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and RingCentral Inc. Class A Common Stock for 1 Days on average.
| HALO | RNG | |
|---|---|---|
Market Cap | $12.58B | $6.54B |
Volume | 2,179,278 | 1,543,570 |
Sector | Health | Technology |
52-Week High | $115.22 | $79.82 |
52-Week Low | $61.63 | $24.82 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $7.60B |
Dividend Yield | — | 0.35% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About RingCentral Inc. Class A Common Stock
RingCentral provides cloud-based business communications and contact center solutions. Its platform combines phone, messaging, video meetings, and customer-service tools.
Read more on RNG →
